Overview

Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency

Status:
Not yet recruiting

Trial end date:
2022-10-10

Target enrollment:

Participant gender:

Summary

Emergency treatment warning of clevidipine butyrate butyrate injection or invalid medical treatment and verification of the effectiveness and safety of subacute.

Phase:

Phase 3

Details

Lead Sponsor:

Shenzhen People's Hospital

Treatments:

Clevidipine